Acute cerebellar syndrome following intermediate-dose cytarabine

Br J Haematol. 2001 Jun;113(4):846. doi: 10.1046/j.1365-2141.2001.02771.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antimetabolites, Antineoplastic / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Ataxia / chemically induced
  • Brain / pathology*
  • Cisplatin / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Cytarabine / adverse effects*
  • Cytarabine / therapeutic use
  • Dexamethasone / therapeutic use
  • Doxorubicin / therapeutic use
  • Dysarthria / chemically induced
  • Dysarthria / diagnosis
  • Gait Ataxia / chemically induced*
  • Gait Ataxia / diagnosis
  • Humans
  • Lymphoma, B-Cell / drug therapy
  • Magnetic Resonance Imaging*
  • Male
  • Middle Aged
  • Nystagmus, Pathologic / chemically induced*
  • Nystagmus, Pathologic / diagnosis
  • Prednisone / therapeutic use
  • Syndrome
  • Vincristine / therapeutic use

Substances

  • Antimetabolites, Antineoplastic
  • Cytarabine
  • Vincristine
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin
  • Prednisone

Supplementary concepts

  • CHOP protocol
  • DHAP protocol